| P50 | author | Marcelo E Bigal | Q78653335 |
| P2093 | author name string | Abouch V Krymchantowski | |
| | Pedro F Moreira | |
| P2860 | cites work | Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology | Q28138991 |
| | Vasoactive peptide release in the extracerebral circulation of humans during migraine headache | Q28265001 |
| | Prophylactic treatment of migraine with angiotensin converting enzyme inhibitor (lisinopril): randomised, placebo controlled, crossover study | Q28345604 |
| | Montelukast in the prophylaxis of migraine: a potential role for leukotriene modifiers | Q28376497 |
| | Presumed topiramate-induced bilateral acute angle-closure glaucoma | Q30994352 |
| | Hematologic toxicity of sodium valproate | Q33331641 |
| | Clinical pharmacology of topiramate: a review | Q33893453 |
| | Botulinum toxin type A (BOTOX) for treatment of migraine headaches: an open-label study | Q33927756 |
| | Efficacy of gabapentin in migraine prophylaxis | Q33938297 |
| | Safety of divalproex sodium in migraine prophylaxis: an open-label, long-term study. Long-term Safety of Depakote in Headache Prophylaxis Study Group | Q33941173 |
| | Anticonvulsants for neuropathic pain syndromes: mechanisms of action and place in therapy | Q34112912 |
| | Brain stem activation in spontaneous human migraine attacks | Q34297421 |
| | Lamotrigine. A review of its pharmacological properties and clinical efficacy in epilepsy | Q34306763 |
| | Migraine prophylaxis with divalproex | Q34319651 |
| | Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study | Q71498689 |
| | Pharmacokinetic-pharmacodynamic model relating lisinopril plasma concentrations to regional hemodynamic effects in healthy volunteers | Q71698836 |
| | Magnesium in the prophylaxis of migraine--a double-blind placebo-controlled study | Q71746666 |
| | Epidemiology of headache | Q72256204 |
| | The origin, structure, and pharmacological activity of botulinum toxin | Q72518481 |
| | An extract of Petasites hybridus is effective in the prophylaxis of migraine | Q73044116 |
| | Churg-Strauss syndrome: is there an association with leukotriene modifiers? | Q73203639 |
| | Lamotrigine versus placebo in the prophylaxis of migraine with and without aura | Q73311988 |
| | Guidelines for controlled trials of drugs in migraine: second edition | Q73417055 |
| | Angiotensin-converting enzyme gene deletion polymorphism determines an increase in frequency of migraine attacks in patients suffering from migraine without aura | Q73676409 |
| | Topiramate as an inhibitor of carbonic anhydrase isoenzymes | Q73683760 |
| | A comparison of divalproex with propranolol and placebo for the prophylaxis of migraine without aura | Q73733917 |
| | Botulinum toxin type A as a migraine preventive treatment. For the BOTOX Migraine Clinical Research Group | Q73883800 |
| | Pharmacokinetics and bioavailability of montelukast sodium (MK-0476) in healthy young and elderly volunteers | Q74043621 |
| | Epilepsy | Q74261516 |
| | The occurrence of drug-induced myopia as a transient side effect of topiramate | Q74522906 |
| | Topiramate--safety and tolerability | Q77100617 |
| | Gabapentin relieves trigeminal neuralgia in multiple sclerosis patients | Q77114503 |
| | Valproate-induced hyperandrogenism during pubertal maturation in girls with epilepsy | Q77351112 |
| | Gabapentin. Antiepileptic mechanism of action | Q77431997 |
| | In vitro evaluation of potential drug interactions with levetiracetam, a new antiepileptic agent | Q77939234 |
| | Sodium valproate has a prophylactic effect in migraine without aura: a triple-blind, placebo-controlled crossover study | Q34340026 |
| | Gabapentin: pharmacokinetics, efficacy, and safety | Q34386719 |
| | Sodium valproate in the prophylactic treatment of migraine: a double-blind study versus placebo | Q34402655 |
| | Divalproex sodium in migraine prophylaxis: a dose-controlled study | Q34424847 |
| | Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial | Q34458351 |
| | Clinical pharmacology and therapeutic use of the new antiepileptic drugs | Q34541736 |
| | Migraine and magnesium: eleven neglected connections | Q36429770 |
| | The broad substrate specificity of human angiotensin I converting enzyme | Q38177064 |
| | Valproic acid hepatic fatalities: a retrospective review | Q39593456 |
| | A review of the preclinical pharmacology of tiagabine: a potent and selective anticonvulsant GABA uptake inhibitor | Q40412354 |
| | Models of primary generalized epilepsy. | Q40450706 |
| | The synaptic vesicle and its targets | Q40496728 |
| | Migraine heterogeneity. Disability, pain intensity, and attack frequency and duration | Q40659314 |
| | Single-dose pharmacokinetics and effect of food on the bioavailability of topiramate, a novel antiepileptic drug | Q40924838 |
| | The concept of migraine as a state of central neuronal hyperexcitability | Q41175750 |
| | Functional modulation of ligand-gated GABAA and NMDA receptor channels by phosphorylation | Q41198868 |
| | Divalproex sodium in headache: literature review and clinical guidelines | Q41209903 |
| | Pharmacokinetics of new antiepileptic drugs | Q41240617 |
| | Lisinopril. A review of its pharmacology and clinical efficacy in elderly patients | Q41375165 |
| | Preventive treatment of migraine: an overview | Q41460245 |
| | Tiagabine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the management of epilepsy | Q41733392 |
| | Inhibition of testosterone secretion by S-petasin in rat testicular interstitial cells. | Q42497723 |
| | Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy | Q42539954 |
| | Magnesium prophylaxis of menstrual migraine: effects on intracellular magnesium | Q42622418 |
| | Timing and topography of cerebral blood flow, aura, and headache during migraine attacks | Q43706641 |
| | Bilateral angle-closure glaucoma and ciliary body swelling from topiramate | Q43799707 |
| | Gabapentin as an adjuvant to opioid analgesia for neuropathic cancer pain | Q44352283 |
| | A rational guide to routine blood monitoring in patients receiving antiepileptic drugs | Q44615275 |
| | Cellular actions of topiramate: blockade of kainate-evoked inward currents in cultured hippocampal neurons | Q44870767 |
| | Pharmacological studies on lamotrigine, a novel potential antiepileptic drug: II. Neurochemical studies on the mechanism of action | Q48303242 |
| | Effects of zonisamide (AD-810) on tungstic acid gel-induced thalamic generalized seizures and conjugated estrogen-induced cortical spike-wave discharges in cats | Q48326452 |
| | Wolff Award 1996. The actions of valproate and neurosteroids in a model of trigeminal pain | Q48386553 |
| | Lamotrigine-induced severe cutaneous adverse reactions | Q49092396 |
| | Sex-related pharmacokinetic and pharmacodynamic variations of lisinopril. | Q50972162 |
| | Work-related disability: results from the American migraine study. | Q51011782 |
| | Zonisamide for add-on treatment of refractory partial epilepsy: a European double-blind trial. | Q53022577 |
| | Effectiveness of lamotrigine in the prophylaxis of migraine with aura: an open pilot study. | Q53699726 |
| | Lamotrigine in the prophylactic treatment of migraine aura--a pilot study. | Q53934833 |
| | High-dose riboflavin as a prophylactic treatment of migraine: results of an open pilot study. | Q54023124 |
| | Valproate: a new drug in migraine prophylaxis. | Q54121040 |
| | Clinical pharmacology and therapeutic drug monitoring of zonisamide. | Q54164408 |
| | Churg-Strauss Syndrome in Patients Receiving Montelukast as Treatment for Asthma | Q54263625 |
| | Cerebral and extracranial circulatory disturbances in migraine: pathophysiological implications | Q57025171 |
| | Focal hyperemia followed by spreading oligemia and impaired activation of rcbf in classic migraine | Q57025417 |
| | Methodological requirements for clinical trials in refractory epilepsies--our experience with zonisamide | Q68087388 |
| | Low brain magnesium in migraine | Q69385558 |
| | Preliminary observations on brain energy metabolism in migraine studied by in vivo phosphorus 31 NMR spectroscopy | Q69968741 |
| | Clinical aspects of prostaglandins and leukotrienes in migraine | Q70156845 |
| | Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache Classification Committee of the International Headache Society | Q70213757 |
| | Efficacy and tolerability of gabapentin in clinical practice | Q70987536 |
| P433 | issue | 9 | |
| P921 | main subject | migraine | Q133823 |
| P304 | page(s) | 611-634 | |
| P577 | publication date | 2002-01-01 | |
| P1433 | published in | CNS Drugs | Q5013183 |
| P1476 | title | New and emerging prophylactic agents for migraine | |
| P478 | volume | 16 | |